
There’s a lot of buzz around the concept of decentralized clinical trials, and rightly so, given the lessons learned from our experience with clinical trials during the COVID-19 pandemic. Decentralized trials are executed through telemedicine and mobile or local healthcare providers. They rely on technology (or medical devices) and information sharing to execute a study without the involvement of a large centralized clinic. In a post-COVID world, drug development will likely employ more decentralized trials to reduce the time and cost of trial programs.
Continue reading